Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.
about
The history of COPDEfficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomesLong-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisInhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseInhaled corticosteroids for stable chronic obstructive pulmonary diseaseInhaled corticosteroids for stable chronic obstructive pulmonary diseaseRandomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialEffects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysisCan inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].The optimum timing to wean invasive ventilation for patients with AECOPD or COPD with pulmonary infectionGait speed as a measure of functional status in COPD patientsEfficacy and safety of inhaler steroids in COPD patients: Systematic review and meta-analysis of randomized placebo-controlled trialsChronic obstructive pulmonary diseaseOptimizing management of chronic obstructive pulmonary disease in the upcoming decade.Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment ParadigmInhaled steroids for COPD?Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitisEvidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3)Update in internal medicine.Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 updateSimilarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease.Asthma versus chronic obstructive pulmonary disease--exploring why 'reversibility versus irreversibility' is no longer an appropriate approach.Airway inflammation in asthma and chronic obstructive pulmonary disease with special emphasis on the antigen-presenting dendritic cell: influence of treatment with fluticasone propionate.Home treatment of COPD exacerbations.Stable chronic obstructive pulmonary disease.Are inhaled glucocorticosteroids effective in chronic obstructive pulmonary disease?Recent changes: pulmonary medicine.Determinants of gait speed in COPD.Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study.Differential diagnosis of chronic airflow obstruction.The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD.Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.Novel therapy for COPD.Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation.Management of acute exacerbations of chronic obstructive pulmonary disease.Seretide for obstructive lung disease.Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease.Management of an acute exacerbation of copd: are we ignoring the evidence?Chronic obstructive pulmonary disease . 7: Management of COPDIncident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids?
P2860
Q22305861-67036757-C11A-4ADA-AF6D-6CDFC83FE072Q22306079-D9BB7F5D-C73C-4DF3-898C-02FDE53D0C3CQ24197853-E74271CF-B70B-4E85-8AE9-2383AC9DE874Q24197989-6591F53A-53CE-4DBB-AD58-8F4964C747BEQ24202092-E4480A1B-CBA2-42B5-9E53-17BAB443874DQ24245481-8DF754A1-B241-4018-BDBD-A6AF6D08D50BQ24642534-E01997BF-6949-4D1F-A49C-1B098ACFEA4FQ24797765-B5E3060B-F868-4EAB-B4FD-A4A63B85905DQ25257397-8CBF036C-7158-4EEC-9809-D447A69BAD51Q26752876-ABF0D694-744C-42B3-B426-861E916E5052Q26861187-CC8BA6B4-53AA-44B2-876C-0E62897FF7E3Q27025647-86CF373D-ED53-4ED2-9B8D-F6CA5C4CAC47Q27027955-FE63A4AA-6006-46FB-B00C-4DB3E58F1BC9Q27693341-F3BD53E6-F73F-447D-831A-A4C2FFB8D727Q28087788-2006E6D2-D5D0-484E-9737-3A3A3302625DQ28346522-54E4DD9C-4EFF-4EB3-8BA4-51C687F39BB8Q28364409-B0732145-8ECD-45D7-B1D0-0F703999629FQ28365436-2B9A5CBD-0F33-4A21-9FAB-42A891C2C566Q33588350-48C43F0A-2F09-40C3-BE89-C3AB941947E0Q33591899-F6F3ED28-4F10-49C9-A52B-1A37A6E0DBFDQ33630448-812AC41F-2709-4B49-BBDF-CCDA8617EF30Q33640272-DCE32D6E-2474-4ECD-867D-63517330017FQ33696831-C9D3B2A0-D3E0-4D3F-A14C-F38AD4862EB0Q33713992-64DC5D29-7981-4FC6-9F1B-4E53B27B4F42Q33716242-31729804-9405-4BD8-BFE4-946E3B00CAF2Q33771475-9FDBBD04-7593-4F38-934A-6D25211FBDB2Q33793338-A3C1285F-8E68-4B70-B05D-10ADBC7241C3Q33829637-59CF13BA-4992-4F9B-8614-37C98008F8F8Q33856786-945DEBBF-688D-4D55-9135-2D3E7C30685DQ33930072-C8831117-6C8F-4348-AFBF-41070C1077DFQ33966009-7475920C-5235-4AF5-B502-BA30EB248502Q34065276-61DE62F1-4687-4210-A9ED-FBBE4B8960DBQ34074654-687664DC-C6CE-49DC-A6E2-E6ABE47AB73BQ34202072-B6EE12B5-BC31-4A8E-A173-8370370F6CDEQ34445649-BF0EE8A6-527F-4069-9313-9F8BEE8BD2FBQ34544756-6B19EBAB-96C0-4A7F-88EC-68D0E4A2D69BQ34547011-2293542B-D3B8-48D6-9EBC-484504099E8FQ34938599-7CF0E2B4-F3C1-4682-B409-134B7DE73C8BQ35075588-116BF9A1-8707-4235-93CF-BCC7DDAA160BQ35140742-93B11CFB-B0E6-41BB-9E4D-73EA50C8D5B4
P2860
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Multicentre randomised placebo ...... nternational COPD Study Group.
@en
Multicentre randomised placebo ...... nternational COPD Study Group.
@nl
type
label
Multicentre randomised placebo ...... nternational COPD Study Group.
@en
Multicentre randomised placebo ...... nternational COPD Study Group.
@nl
prefLabel
Multicentre randomised placebo ...... nternational COPD Study Group.
@en
Multicentre randomised placebo ...... nternational COPD Study Group.
@nl
P2093
P921
P1433
P1476
Multicentre randomised placebo ...... nternational COPD Study Group.
@en
P2093
J Efthimiou
K Hollingworth
P L Paggiaro
P304
P356
10.1016/S0140-6736(97)03471-5
P407
P577
1998-03-01T00:00:00Z